FABP2 and COVID-19: Indeed, I-FABP is a relevant prognostic biomarker that is positively correlated with a worse prognosis in COVID-19.61 Thus, although no significant differences in α- and β-diversity were observed in the gut microbiota of post-COVID and control subjects, functional changes were observed in both patients and mice.